The relation between changes of nitric oxide synthase in hippocampus and activities of excitatory amino acid receptor during epilepsy

Acta Physiologica Sinica

Volumn 50, Issue 3, 1998, Pages 367-372

  Ren, Jin Peng ^a   Xia, Hui Li ^a   Cheng, Jie Shi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

DNQX; Epilepsy; Hippocampus; MK 801; Neuronal nitric oxide synthase

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENICILLIN G; QUINOXALINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; ELECTROENCEPHALOGRAPHY; ENZYMOLOGY; EPILEPSY; FEMALE; HIPPOCAMPUS; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; DIZOCILPINE MALEATE; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; MALE; PENICILLIN G; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0346940148     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Berde CB. Nitric oxide: a role in neurotransmission or neuronal toxicity? IASP Newslett, 1992, 20: 2∼3.
2. Bredt DS. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature, 1990, 347: 768 ∼770.
3. Smith SE. The nitrc oxide synthnase product, L-citrulline and the nitric oxide doner, SIN-1 are convulsant, while L-arginine is anticonvulsant in rodents with inbred reflex epilepsy. Br J Pharmacol, 1991, 117 (1): 120 ∼127.
4. Proctor MR, Fornai F, Afshar JKB, et al. The role of nitric oxide in focally-evoked limbic seizures. Neuroscience, 1997, 76 (4), 1231∼1236.
5. Smith, SE, Man CM, Yip PK, et al. Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br J Pharmacol, 1996, 119: 165∼173.
6. Wang BE, Cheng JS. Alterations of nitric oxide synthase mRNA level in rat hippocampus during epilepsy and eletro-acupuncture anticonvulsion. Acta Acad Med Shanghai, 1994, 21 (suppl): 110 (in Chinese with English abstract).
7. Lipton SA, Chol YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature, 1993, 364: 626∼631.
8. Vornov JJ, Tasker RC, Coyle JT. Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA and Kainate neurotoxicity in organotypic hippocampal cultures. Exp Neural, 1991, 114: 11.
9. Berg M, Bruhn T, Johansen FF, et al. Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA-and AMPA-receptor antagonists. Pharmacol Toxiol, 1993, 73 (5): 262∼268.
10. McDonald JW, Silverstein FS, Cardona D et al. Systemic administration of MK-801 protects against N-methyl-D-aspartate-and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience, 1990, 36 (3), 589∼599.
11. Wang BE, Cheng JS. Changes of hippocampal amino acid level and NMDA receptor during epilepsy and electroacupuncture. Acta Acad Med Shanghai, 1994, 21 (suppl): 10∼14 (in Chinese with English abstract).
12. Zhang WQ, Hudson PM, Sobotka TJ, et al. Extracellular concentrations of amino acid transmitters in ventral hippocampus during and after the development of kindling. Brain Res, 1991, 540: 315∼318.
13. De-Sarro-GB, Donate-Di-Paoli-E, De-Sarro-A, et al. Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam Clin Pharmacol, 1991,5 (6), 503∼511.
14. Rowley HL, Ellis Y, Davies JA. Age-related effects of NMDA-stimulated concomitant release of mitric oxide and glutamate in cortical slices prepared from DAB/2 mice. Brain Res, 1993, 613, 49∼53.
15. Dawson VL, Dawson TM, London ED, et al. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA, 1991, 88: 6358∼6371.
16. Radi B, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of Superoxide and nitric oxide. Arch Biochem Biaphys, 1991, 288, 481∼487.
17. Clifford DB, Blney JW, Benz AM, et al. Ketamine, phencyclidine, and MK-801 protect against kainic acidinduced seizure-related brain damage. Epilepsia, 1990, 31 (4): 382∼390.